Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 13/20 | 0.49 |
| ▸ | KIT | P10721 | 8/20 | 0.49 |
| ▸ | AURKA | O14965 | 2/20 | 0.49 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.49 |
| ▸ | AXL | P30530 | 4/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4038128 | 0.81 | FLT3 (0.47) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12780516 | 0.81 | FLT3 (0.47) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12779811 | 0.81 | FLT3 (0.50) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12780020 | 0.81 | KIT (0.52) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL4047032 | 0.80 | FLT3 (0.48) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12780520 | 0.80 | FLT3 (0.48) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12780517 | 0.80 | FLT3 (0.48) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL4036619 | 0.80 | FLT3 (0.45) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL12780541 | 0.80 | FLT3 (0.45) | FLT3KITAURKAIRAK4AXL | |
| SCHEMBL4043076 | 0.79 | FLT3 (0.73) | FLT3KITAURKAIRAK4AXL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1562589-B1 | DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES | VERTEX PHARMA (US) | 2009-01-07 | — | — | EP | disclosed |